Scribe Therapeutics
Ross White has two years of research experience. Ross began their career in 2017 as a Research Assistant at Nomura Research Group. In 2019, they joined Scribe Therapeutics as a Research Specialist.
Ross White attended the University of California, Berkeley from 2017 to 2019, where they earned a Bachelor of Science in Chemical Biology.
This person is not in the org chart
Scribe Therapeutics
1 followers
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.